Hi-tech Pharmacal Co, Inc. (HITK) Cash Flow Statement

Click line-items for a historical chart and %

Condensed Consolidated Statements Of Cash Flows
NET CASH FLOWS PROVIDED BY OPERATING ACTIVITIES OF CONTINUING OPERATIONS	-9.07M
NET CASH FLOWS PROVIDED BY OPERATING ACTIVITIES OF DISCONTINUED OPERATIONS
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment	-6.4M
Proceeds from the sale of intangible assets	74K
Purchase of intangible assets	-2.48M
Purchase of ECR Pharmaceuticals assets
NET CASH (USED IN) INVESTING ACTIVITIES OF CONTINUING OPERATIONS	-10.72M
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of common stock and exercise of options	5.49M
Tax benefits of stock incentives	1.39M
Borrowings from long-term debt
Payment of capital lease obligation
NET CASH PROVIDED BY FINANCING ACTIVITIES OF CONTINUING OPERATIONS	5.63M
NET INCREASE IN CASH AND CASH EQUIVALENTS	-14.16M
Cash and cash equivalents at beginning of the period	100.61M
CASH AND CASH EQUIVALENTS AT END OF PERIOD	86.45M
Supplemental disclosures of cash flow information:
Interest paid	245K
Income taxes paid	11.23M
Supplemental disclosures of non-cash investing transactions:
Obligation related to purchase of intangible assets included in accrued expenses

Entities mentioned with HITK